NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/16/2021
Back to search
Official data from USPTO
UNITED THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
UNITED THERAPEUTICS
ST13
US500000075979826Class
5
Filing
75979826
Registration
2468539
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
09/16/2021
Trademark type
Word
Nice classes
5
Filing date
12/05/1997
Registration date
07/10/2001
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/16/2021
Last transaction
09/16/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/08/1997
First use in commerce
12/08/1997
Drawing code
1
Owner type
03
Owner location
Silver Spring, MD
Examiner
WILLIAMS KELLY L.
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
U. C. (pessoa física)
U. C. (pessoa física)
LRX Pharmaceuticals, Inc.
Representatives
Norm J. Rich Foley & Lardner LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the treatment of chronic conditionschronic heart diseasechronic vascular diseasechronic lung disease
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
09/16/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/16/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/16/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
05/17/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/10/2020
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/06/2011
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/06/2011
E89R
TEAS SECTION 8 & 9 RECEIVED
05/05/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/18/2007
PLGL
ASSIGNED TO PARALEGAL
07/16/2007
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
06/21/2007
E815
TEAS SECTION 8 & 15 RECEIVED
06/21/2007
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/21/2007
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/21/2007
CFIT
CASE FILE IN TICRS
10/13/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
07/10/2001
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/26/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/11/2000
CNRT
NON-FINAL ACTION MAILED
09/07/2000
DPCC
DIVISIONAL PROCESSING COMPLETE
08/04/2000
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/02/2000
IUAF
USE AMENDMENT FILED
01/21/2000
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
12/21/1999
PUBO
PUBLISHED FOR OPPOSITION
09/28/1999
NPUB
NOTICE OF PUBLICATION
08/27/1999
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/19/1999
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/20/1999
CNSL
LETTER OF SUSPENSION MAILED
03/15/1999
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/1999
CNSL
LETTER OF SUSPENSION MAILED
09/22/1998
CNEA
EXAMINER'S AMENDMENT MAILED
09/04/1998
DOCK
ASSIGNED TO EXAMINER
08/10/1998
Continuous trademark protection
Get notified about every new filing that threatens UNITED THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.